Yüklüyor......
New emerging targets in cancer immunotherapy: the role of GITR
In the last decade, immunotherapies have revolutionised anticancer treatment. However, there is still a number of patients that do not respond or acquire resistance to these treatments. Despite several efforts to combine immunotherapy with other strategies like chemotherapy, or other immunotherapy,...
Kaydedildi:
| Yayımlandı: | ESMO Open |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7451269/ https://ncbi.nlm.nih.gov/pubmed/32817129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000738 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|